These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12920022)
1. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Gojova A; Brun V; Esposito B; Cottrez F; Gourdy P; Ardouin P; Tedgui A; Mallat Z; Groux H Blood; 2003 Dec; 102(12):4052-8. PubMed ID: 12920022 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Gisterå A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK Sci Transl Med; 2013 Jul; 5(196):196ra100. PubMed ID: 23903754 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Lutgens E; Gijbels M; Smook M; Heeringa P; Gotwals P; Koteliansky VE; Daemen MJ Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):975-82. PubMed ID: 12067907 [TBL] [Abstract][Full Text] [Related]
4. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. Robertson AK; Rudling M; Zhou X; Gorelik L; Flavell RA; Hansson GK J Clin Invest; 2003 Nov; 112(9):1342-50. PubMed ID: 14568988 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Pinderski LJ; Fischbein MP; Subbanagounder G; Fishbein MC; Kubo N; Cheroutre H; Curtiss LK; Berliner JA; Boisvert WA Circ Res; 2002 May; 90(10):1064-71. PubMed ID: 12039795 [TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732 [TBL] [Abstract][Full Text] [Related]
7. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364 [TBL] [Abstract][Full Text] [Related]
8. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Levéen P; Larsson J; Ehinger M; Cilio CM; Sundler M; Sjöstrand LJ; Holmdahl R; Karlsson S Blood; 2002 Jul; 100(2):560-8. PubMed ID: 12091349 [TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice. Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018 [TBL] [Abstract][Full Text] [Related]
10. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. Shah AH; Tabayoyong WB; Kimm SY; Kim SJ; Van Parijs L; Lee C J Immunol; 2002 Oct; 169(7):3485-91. PubMed ID: 12244137 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631 [TBL] [Abstract][Full Text] [Related]
12. TGF-beta regulates airway responses via T cells. Schramm C; Herz U; Podlech J; Protschka M; Finotto S; Reddehase MJ; Köhler H; Galle PR; Lohse AW; Blessing M J Immunol; 2003 Feb; 170(3):1313-9. PubMed ID: 12538691 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis. Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149 [TBL] [Abstract][Full Text] [Related]
14. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Larsson J; Blank U; Helgadottir H; Björnsson JM; Ehinger M; Goumans MJ; Fan X; Levéen P; Karlsson S Blood; 2003 Nov; 102(9):3129-35. PubMed ID: 12842983 [TBL] [Abstract][Full Text] [Related]
16. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335 [TBL] [Abstract][Full Text] [Related]